share_log

Aerpio Pharmaceuticals Q2 EPS $(0.09) Down From $0.23 YoY

Benzinga Real-time News ·  Aug 11, 2021 16:11

Aerpio Pharmaceuticals (NASDAQ:ARPO) reported quarterly losses of $(0.09) per share. This is a 139.13 percent decrease over earnings of $0.23 per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment